Neonatal Phase 1 Valacyclovir Study

NCT05468619 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

NIH

Sponsor class

Conditions

Herpes Simplex

Interventions

DRUG: Valacyclovir

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)